Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.0241 | 0.4144 | 1 | |
Mycobacterium ulcerans | carbon monoxyde dehydrogenase large chain CoxL | 0.0068 | 0.0876 | 0.2678 |
Mycobacterium tuberculosis | Probable carbon monoxyde dehydrogenase (medium chain) | 0.0077 | 0.1053 | 0.5229 |
Mycobacterium tuberculosis | Probable carbon monoxyde dehydrogenase (large chain) | 0.0108 | 0.1629 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0022 | 0.0007 | 0.0018 |
Entamoeba histolytica | acetyltransferase, GNAT family | 0.0022 | 0.0015 | 0.5 |
Echinococcus granulosus | Hepatocellular carcinoma associated antigen 59 | 0.0241 | 0.4144 | 0.414 |
Mycobacterium ulcerans | carbon monoxide dehydrogenase | 0.0151 | 0.245 | 1 |
Mycobacterium ulcerans | aerobic-type carbon monoxide dehydrogenase subunit CoxL_2 | 0.0108 | 0.1629 | 0.618 |
Mycobacterium ulcerans | carbon monoxyde dehydrogenase large chain CoxL | 0.0108 | 0.1629 | 0.618 |
Mycobacterium ulcerans | carbon monoxyde dehydrogenase small chain CoxS | 0.0044 | 0.0422 | 0.0568 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0079 | 0.1094 | 0.1088 |
Trichomonas vaginalis | aldehyde oxidase, putative | 0.0228 | 0.3902 | 1 |
Loa Loa (eye worm) | acetyltransferase | 0.0082 | 0.1138 | 0.2745 |
Treponema pallidum | hypothetical protein | 0.0037 | 0.03 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0241 | 0.4144 | 1 |
Schistosoma mansoni | gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 | 0.0082 | 0.1138 | 0.1131 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0022 | 0.0007 | 0.0018 |
Loa Loa (eye worm) | hypothetical protein | 0.0241 | 0.4144 | 1 |
Mycobacterium ulcerans | aerobic-type carbon monoxide dehydrogenase subunit CoxM_2 | 0.0077 | 0.1053 | 0.3502 |
Mycobacterium ulcerans | carbon monoxyde dehydrogenase medium chain CoxM | 0.0077 | 0.1053 | 0.3502 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0024 | 0.0053 | 0.0045 |
Treponema pallidum | quinoline 2-oxidoreductase | 0.0036 | 0.0284 | 0.8682 |
Plasmodium falciparum | conserved protein, unknown function | 0.0241 | 0.4144 | 1 |
Brugia malayi | acetyltransferase, GNAT family protein | 0.0082 | 0.1138 | 0.2732 |
Trichomonas vaginalis | xanthine dehydrogenase, putative | 0.0228 | 0.3902 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0241 | 0.4144 | 0.414 |
Toxoplasma gondii | hypothetical protein | 0.0241 | 0.4144 | 1 |
Brugia malayi | Hepatocellular carcinoma-associated antigen 59 family protein | 0.0241 | 0.4144 | 1 |
Loa Loa (eye worm) | intermediate filament protein | 0.0022 | 0.0007 | 0.0018 |
Mycobacterium ulcerans | carbon monoxyde dehydrogenase small chain CoxS | 0.0044 | 0.0422 | 0.0568 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0552 | 1 | 1 |
Giardia lamblia | Histone acetyltransferase GCN5 | 0.0022 | 0.0015 | 0.5 |
Onchocerca volvulus | 0.0241 | 0.4144 | 1 | |
Trichomonas vaginalis | xanthine dehydrogenase, putative | 0.0228 | 0.3902 | 1 |
Echinococcus multilocularis | Hepatocellular carcinoma associated antigen 59 | 0.0241 | 0.4144 | 0.414 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0552 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0241 | 0.4144 | 1 |
Echinococcus multilocularis | gcn5proteinral control of amino acid synthesis | 0.0082 | 0.1138 | 0.1131 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (ADMET) | = 0 % | Phytotoxicity against directly seeded Oryza sativa (rice) seedlings assessed as phytotoxic activity ratings (0- no effect to 5-complete killing rating scale) at 100 g/a measured after 3 weeks post compound treatment under green house conditions | ChEMBL. | 27393589 |
Activity (functional) | = 85 % | Relieving activity against bensulfuron-methyl induced injury to Oryza sativa (rice) assessed as growth rate at 1 uM (Rbv = 46 to 53%) | ChEMBL. | 27393060 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.